Evidence map›Paper›PMID 40374819›Full record

ArticleBiological trace element research2025

Bio-inspired Synthesis, Characterization, and Biomedical Applications of Optimized Ceiba pentandra Silver Nanoparticles.

Loick Pradel Kojom Foko, Joseph Hawadak, Philippe Belle Ebanda Kedi, Veena Pande, Vineeta Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Loick Pradel Kojom FokoParasite and Host Biology Group, ICMR-National Institute of Malaria Research, New Delhi, 110077, India.ORCID http://orcid.org/0000-0002-4286-147X
Joseph HawadakParasite and Host Biology Group, ICMR-National Institute of Malaria Research, New Delhi, 110077, India.ORCID http://orcid.org/0000-0003-4145-9953
Philippe Belle Ebanda KediLaboratory of Innovative Nanostructured Material (NANO: C), Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, 2701, Cameroon.ORCID http://orcid.org/0000-0003-4578-0752
Veena PandeDepartment of Biotechnology, Kumaun University, 263001, Bhimtal, Uttarakhand, India.ORCID http://orcid.org/0000-0002-4839-7276
Vineeta SinghParasite and Host Biology Group, ICMR-National Institute of Malaria Research, New Delhi, 110077, India. vineetas_2000@yahoo.com.ORCID http://orcid.org/0000-0003-0113-7394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green nanotechnology can provide new avenues for drug and insecticide discovery. This study aimed at synthesizing and evaluating the potential of silver nanoparticles, using an innovative plant-driven synthesis approach, with the potential to be used as an endectocide. Optimized silver nanoparticles using Ceiba pentandra (CP-AgNPs) were evaluated for their hemotoxic and killing activities against the deadliest malaria parasite Plasmodium falciparum (Pf) and three mosquito species (Culex quinquefasciatus, Anopheles stephensi, and Aedes aegypti) of medical importance. Optimized CP-AgNPs were predominantly spheroidal, stable, polycrystalline, and coated with several phytochemical compounds, including terpenoids, alkaloids, and phenols. CP-AgNPs exhibited good hemocompatibility and high lethal activity on Pf 3D7 and RKL9 strains, with respective IC

Indexed as

AntimalarialsInsecticidesMetal NanoparticlesSilverAedesAnimalsAnophelesPlant ExtractsPlasmodium falciparumAntimalarialsInsecticidesPlant ExtractsSilverAntiplasmodial activitiesCeiba pentandraCharacterizationGreen synthesisHemotoxicityLarvicidal activityMetal nanoparticlesOptimization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.